Editorial commentary on “Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo”

Detalles Bibliográficos
Autores principales: Yamanishi, Tomonori, Kamasasko, Tomohiko, Kaga, Kanya, Fuse, Miki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354321/
https://www.ncbi.nlm.nih.gov/pubmed/32676385
http://dx.doi.org/10.21037/tau-2020-02

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354321/
https://www.ncbi.nlm.nih.gov/pubmed/32676385
http://dx.doi.org/10.21037/tau-2020-02

Ejemplares similares